Journal article icon

Journal article

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.

Abstract:

OBJECTIVES: We sought to assess the ability of N-terminal pro-B-type natriuretic peptide (N-BNP) to predict vascular events in high-risk people and to test whether statins benefit people with high levels of N-BNP.

BACKGROUND: The predictive value of N-BNP for occlusive vascular events and the effects of statins in people with high N-BNP levels are uncertain.

METHODS: A total of 20,536 people were assigned randomly to simvasta...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher version

Actions


Access Document


Files:
Publisher copy:
10.1016/j.jacc.2006.08.052

Authors


Emberson, JR More by this author
Armitage, J More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Trial Service Unit, BHF Centre of Research Excellence
Expand authors...
Medical Research Council More from this funder
British Heart Foundation More from this funder
Merck and Co. More from this funder
Roche Vitamins Ltd. More from this funder
Publisher:
Elsevier B.V. Publisher's website
Journal:
Journal of the American College of Cardiology Journal website
Volume:
49
Issue:
3
Pages:
311-319
Publication date:
2007-01-05
DOI:
EISSN:
1558-3597
ISSN:
0735-1097
URN:
uuid:36f306e8-24e3-4853-b17a-1a3082a28236
Source identifiers:
33731
Local pid:
pubs:33731

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP